3-69118811-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_198271.5(LMOD3):c.1544T>A(p.Ile515Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,609,052 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_198271.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LMOD3 | ENST00000420581.7 | c.1544T>A | p.Ile515Asn | missense_variant | Exon 2 of 3 | 1 | NM_198271.5 | ENSP00000414670.3 | ||
LMOD3 | ENST00000475434.1 | c.1544T>A | p.Ile515Asn | missense_variant | Exon 3 of 4 | 5 | ENSP00000418645.1 | |||
LMOD3 | ENST00000489031.5 | c.1544T>A | p.Ile515Asn | missense_variant | Exon 3 of 4 | 2 | ENSP00000417210.1 |
Frequencies
GnomAD3 genomes AF: 0.0000136 AC: 2AN: 147430Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.00000402 AC: 1AN: 248818Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134968
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461622Hom.: 0 Cov.: 33 AF XY: 0.0000124 AC XY: 9AN XY: 727100
GnomAD4 genome AF: 0.0000136 AC: 2AN: 147430Hom.: 0 Cov.: 30 AF XY: 0.0000140 AC XY: 1AN XY: 71646
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.1544T>A (p.I515N) alteration is located in exon 2 (coding exon 2) of the LMOD3 gene. This alteration results from a T to A substitution at nucleotide position 1544, causing the isoleucine (I) at amino acid position 515 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Nemaline myopathy 10 Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with LMOD3-related disease. This variant is present in population databases (rs747837263, ExAC 0.002%). This sequence change replaces isoleucine with asparagine at codon 515 of the LMOD3 protein (p.Ile515Asn). The isoleucine residue is highly conserved and there is a large physicochemical difference between isoleucine and asparagine. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at